Management of Fibrosis: The Mesenchymal Stromal Cells Breakthrough
Fibrosis is the endpoint of many chronic inflammatory diseases and is defined by an abnormal accumulation of extracellular matrix components. Despite its slow progression, it leads to organ malfunction. Fibrosis can affect almost any tissue. Due to its high frequency, in particular in the heart, lun...
Saved in:
Main Authors: | Benoît Usunier (Author), Marc Benderitter (Author), Radia Tamarat (Author), Alain Chapel (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2014-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-Term Quantitative Biodistribution and Side Effects of Human Mesenchymal Stem Cells (hMSCs) Engraftment in NOD/SCID Mice following Irradiation
by: Sabine François, et al.
Published: (2014) -
Effect of culture environement on mesenchymal stem cell immunomodulatory ability
by: Aisha Nasef, et al.
Published: (2020) -
Mesenchymal Stromal Cells Support Endometriotic Stromal Cells In Vitro
by: Fawaz Abomaray, et al.
Published: (2018) -
Mesenchymal stromal cells in the thymus
by: Takeshi Nitta
Published: (2022) -
Directional Topography Influences Adipose Mesenchymal Stromal Cell Plasticity: Prospects for Tissue Engineering and Fibrosis
by: Gabriel Romero Liguori, et al.
Published: (2019)